FormBlends vs Zovo
Zovo
One price, 16 privacy-first Chrome extensions built by you and for you.
Last updated: February 27, 2026
Visual Comparison
FormBlends

Zovo

Overview
About FormBlends
FormBlends is a telehealth platform for GLP-1 weight loss, hormone replacement therapy, and peptide programs. Our GLP-1 plans use semaglutide and tirzepatide, the same compounds behind Ozempic and Mounjaro, with clinical trials showing up to 22.5% body weight reduction. We also offer HRT and a full range of peptide therapies for performance, recovery, and overall wellness. Every program starts with a licensed physician who builds a personalized plan for you. No insurance hoops, no waiting rooms, no overpriced clinic visits. Pharmaceutical-grade compounds shipped straight to your door at a fraction of what brand names cost. We handle prescriptions, provider check-ins, and ongoing support so you can just focus on results. Free consultation to start, most people have their plan within days.
About Zovo
Zovo is an innovative suite of 20 Chrome extensions designed to enhance your browsing experience, meticulously crafted by a solo developer with over a decade of experience and a remarkable track record of $400K+ earned on Upwork with a 100% success rate. At the heart of Zovo is its flagship extension, BeLikeNative, which empowers more than 3,300 users to write like native speakers across 80 languages with the simple press of a key. The Zovo suite includes essential tools like Tab Suspender Pro, JSON Formatter Pro, Clipboard History Pro, Form Filler Pro, and many more, all focused on delivering privacy-first solutions where no data ever leaves your device. With a community-driven approach, users can vote on features and shape the product roadmap, ensuring that Zovo evolves to meet their needs. New extensions are released monthly, with early access for members. Many tools are also available for free online at zovo.one, making Zovo a comprehensive solution for anyone looking to enhance their productivity while safeguarding their privacy.